VIC Tech
Robyn Goforth, PhD, Vice President Technology Assessment, also presently serving as Chief Scientific Officer for portfolio company BiologicsMD. At BiologicsMD she oversees pre-clinical drug development programs for the pipeline of products for treatment of alopecia, severe bone disorders, and metastatic breast and prostate cancers.
Her primary areas of technical focus are drug development, pharmaceutical manufacturing, and regulatory strategy. With VIC’s Opportunity Assessment Team, Dr. Goforth leads technical and commercial evaluation of technologies ranging from medical devices to pharmaceuticals as well as scientific research tools and instrumentation.
Dr. Goforth has been the principal investigator on over $3M in Small Business Innovation Research and Department of Defense grants and has served as co-principal investigator on over $10MM in National Institutes of Health and Department of Energy grants. Dr. Goforth earned her Doctorate degree in Chemistry from the University of Arkansas in 2001.
VIC Tech
VIC is a private, for-profit technology venture development firm in the business of forming new technology companies with the purpose of commercializing licensed technologies, providing an extensive business development team to provide the initial business leadership and other support for the formed companies, and providing management/corporate services to those portfolio companies on a pro-rata cost basis.